Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours

Summary: Background: PT-112, the first pyrophosphate-platinum conjugate, causes immunogenic cell death in experimental models, leading to recruitment of tumour-infiltrating lymphocytes. PT-112 also associates with bone (osteotropism), likely driven by its pyrophosphate moiety. This is the first-in-...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Daniel D. Karp, D. Ross Camidge, Jeffery R. Infante, Tyler D. Ames, Matthew R. Price, José Jimeno, Alan H. Bryce
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2022-07-01
Saila:	EClinicalMedicine
Gaiak:	Phase I clinical trials Small molecule agent Lung cancer Prostate cancer Pharmacokinetics Immunogenic cell death
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2589537022001602
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!